Synthetic biochemistry seeks to engineer complex metabolic pathways for chemical conversions outside the constraints of the cell. Establishment of effective and flexible cell-free systems requires the ...

Cambridge, Massachusetts-based biotech company Rheostat Therapeutics announced it has raised $23 million in Series A funding to develop potential treatments for neurodegenerative diseases, cognition, ...

St. Jude Children's Research Hospital scientists have determined how a protein's disordered region serves as a molecular rheostat to help regulate cell survival. The survival drama is played out ...

Rheostat Therapeutics, a young biotech firm focused on treatments for neurodegeneration, cognition, and rare diseases, secured $23 million in its first formal round of funding. Rheostat is developing ...